The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.

A series of potent phthalazinone-based human H(1) and H(3) bivalent histamine receptor antagonists, suitable for intranasal administration for the potential treatment of allergic rhinitis, were identified. Blockade of H(3) receptors is thought to improve efficacy on nasal congestion, a symptom of allergic rhinitis that is currently not treated by current antihistamines. Two analogues (56a and 56b) had slightly lower H(1) potency (pA(2) 9.1 and 8.9, respectively, vs 9.7 for the clinical gold-standard azelastine, and H(3) potency (pK(i) 9.6 and 9.5, respectively, vs 6.8 for azelastine). Compound 56a had longer duration of action than azelastine, low brain penetration, and low oral bioavailability, which coupled with the predicted low clinical dose, should limit the potential of engaging CNS-related side-effects associated with H(1) or H(3) antagonism.
AuthorsPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, Kenneth L Clark, Lise Fechner, Paul M Gore, Ashley P Hancock, Simon T Hodgson, Duncan S Holmes, Michael Kranz, Brian E Looker, Karen M L Morriss, Daniel L Parton, Linda J Russell, Robert J Slack, Steven L Sollis, Sadie Vile, Clarissa J Watts
JournalJournal of medicinal chemistry (J Med Chem) Vol. 54 Issue 7 Pg. 2183-95 (Apr 14 2011) ISSN: 1520-4804 [Electronic] United States
PMID21381763 (Publication Type: Journal Article)
Chemical References
  • Histamine H1 Antagonists
  • Histamine H3 Antagonists
  • Phthalazines
  • Receptors, Histamine H1
  • Receptors, Histamine H3
  • phthalazine
  • Administration, Intranasal
  • Administration, Oral
  • Drug Discovery (methods)
  • Histamine H1 Antagonists (administration & dosage, chemistry, pharmacology, therapeutic use)
  • Histamine H3 Antagonists (administration & dosage, chemistry, pharmacology, therapeutic use)
  • Humans
  • Models, Molecular
  • Phthalazines (administration & dosage, chemistry, pharmacology, therapeutic use)
  • Protein Conformation
  • Receptors, Histamine H1 (chemistry, metabolism)
  • Receptors, Histamine H3 (metabolism)
  • Rhinitis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: